SBC Medical Group (NASDAQ:SBC) Announces Earnings Results

SBC Medical Group (NASDAQ:SBC) issued its earnings results on Friday. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.01), Zacks reports. SBC Medical Group had a return on equity of 20.76% and a net margin of 17.71%.

SBC Medical Group Stock Performance

Shares of SBC Medical Group stock traded down $0.05 during trading hours on Friday, reaching $3.31. 61,716 shares of the stock traded hands, compared to its average volume of 40,538. SBC Medical Group has a one year low of $2.62 and a one year high of $7.99. The firm has a market capitalization of $343.84 million, a price-to-earnings ratio of 10.34 and a beta of 1.27. The company has a quick ratio of 3.95, a current ratio of 3.98 and a debt-to-equity ratio of 0.03. The company has a 50 day moving average price of $4.00 and a 200 day moving average price of $4.21.

Institutional Trading of SBC Medical Group

Large investors have recently added to or reduced their stakes in the business. XTX Topco Ltd bought a new position in SBC Medical Group during the second quarter valued at approximately $64,000. New York State Common Retirement Fund purchased a new stake in SBC Medical Group during the second quarter valued at approximately $104,000. Finally, Geode Capital Management LLC bought a new stake in shares of SBC Medical Group in the 2nd quarter valued at approximately $455,000. 60.82% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

SBC has been the subject of several analyst reports. Maxim Group initiated coverage on shares of SBC Medical Group in a research report on Wednesday, November 5th. They set a “buy” rating and a $9.00 price target for the company. Weiss Ratings reiterated a “sell (d)” rating on shares of SBC Medical Group in a research note on Wednesday, November 5th. Finally, Wall Street Zen raised SBC Medical Group from a “hold” rating to a “buy” rating in a research report on Saturday, September 20th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $9.00.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.